Atlas Trials

Circulating Blood Profile to Predict Recurrence and Response to Systemic Therapy

Clinical trial NCT03267381 · COMPLETED

Trial details

NCT number
NCT03267381
Sponsor
Vanderbilt-Ingram Cancer Center
Status
COMPLETED
Study type
OBSERVATIONAL
Melanoma
Start date
2017-10-03
Primary completion
2023-09-27
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.